Geron grants inducement stock options
Analysis based on 7 articles · First reported Jul 14, 2026 · Last updated Jul 22, 2026
The grants are routine inducements for new hires and have minimal direct market impact. Geron's stock price remains near the grant prices, reflecting no significant change.
Geron Corporation, a commercial-stage biopharmaceutical company, granted inducement stock options to new employees. On July 13, 2026, it granted an option to purchase 1,700,000 shares to new Chief Business Officer Chinmaya Rath at $1.42 per share. On July 17, 2026, it granted options for 202,500 shares to five other new hires at $1.44 per share. The options vest over four years and were approved under Nasdaq Listing Rule 5635(c)(4).
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard